RR MM
Showing 1 - 25 of 3,942
Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)
Recruiting
- Multiple Myeloma
- anti-BCMA/GPRC5D CAR-T CELL
-
Xuzhou, Jiangsu, ChinaKailin Xu
Aug 19, 2022
Carfilzomib in Combination for the Treatment of RR MM
Unknown status
- Multiple Myeloma
- +2 more
-
Samsun, Turkey19 Mayıs University Faculty of Medicine
Jun 27, 2019
Diabetes, Type 2 Trial (Magnetic mitohormesis)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Magnetic mitohormesis
- (no location specified)
May 30, 2023
Multiple Myeloma, Amyloidosis Trial in Jacksonville, New York, Cleveland (APG-2575+ Pd, APG-2575 + DRd)
Recruiting
- Multiple Myeloma
- Amyloidosis
- APG-2575+ Pd
- APG-2575 + DRd
-
Jacksonville, Florida
- +2 more
Feb 28, 2022
Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))
Recruiting
- Immunotherapy
- Multiple Myeloma
- Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Dec 14, 2022
Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Elotuzumab
- Belantamab mafodotin
-
New Haven, ConnecticutYale New Haven Hospital
Aug 15, 2022
Heart Rate and Respiratory Rate for Heart Failure
Recruiting
- Heart Failure
- +2 more
- WHOOP strap 3.0
-
Hershey, PennsylvaniaPenn State Hershey Medical Center
Nov 23, 2021
Acute Respiratory Distress Syndrome Trial in Boston (ASV, Lung Protective Ventilation)
Completed
- Acute Respiratory Distress Syndrome
- ASV
- Lung Protective Ventilation
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 7, 2022
Fluoroquinolone Resistance Prevalence Study
Recruiting
- Multiple Myeloma
-
Washington, District of Columbia
- +1 more
Apr 10, 2023
Coronary Artery Disease, Heart Failure Systolic Trial (Revascularization by PCI, Revascularization by CABG)
Not yet recruiting
- Coronary Artery Disease
- Heart Failure Systolic
- Revascularization by PCI
- Revascularization by CABG
- (no location specified)
Jul 13, 2022
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
Recruiting
- Neurofibromatosis 2
- Bevacizumab Zirconium Zr-89
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Jan 5, 2023
Varicose Veins, Dilated Veins Trial in Arnhem (Mechano-chemical ablation)
Completed
- Varicose Veins
- Dilated Veins
- Mechano-chemical ablation
-
Arnhem, Gelderland, NetherlandsRijnstate Hospital
Apr 26, 2022
Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of
Recruiting
- Lung Cancer
- +2 more
-
Palo Alto, CaliforniaVA Palo Alto Health Care System
Oct 6, 2022
Patterns and Disease Control in cHL and sALCL in Routine
Completed
- Hodgkin Disease
- Lymphoma, Large-cell, Anaplastic
-
Astrakhan, Russian Federation
- +49 more
Dec 19, 2022
Paroxysmal Atrial Fibrillation Trial (cryoablation of atrial fibrillation using only 28 mm size balloon, cryoablation of atrial
Not yet recruiting
- Paroxysmal Atrial Fibrillation
- cryoablation of atrial fibrillation using only 28 mm size balloon
- cryoablation of atrial fibrillation using expandable balloon (28 / 31 mm)
- (no location specified)
Sep 23, 2023
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
Multiple Myeloma Trial in Beijing, Suzhou (CAR-BCMA T Cells)
Recruiting
- Multiple Myeloma
- CAR-BCMA T Cells
-
Beijing, Beijing, China
- +1 more
Jan 26, 2023
Respiration Rate, Heart Rate Trial (VSC-MEDlib)
Not yet recruiting
- Respiration Rate
- Heart Rate
- VSC-MEDlib
- (no location specified)
Nov 16, 2023
Surgery--Complications Trial in Paris, Suresnes (Biobeat patch)
Recruiting
- Surgery--Complications
- Biobeat patch
-
Paris, France
- +1 more
Jan 12, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- IMCY-0141
- +2 more
-
Chisinau, Moldova, Republic ofRepublican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022
Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)
Completed
- Normoglycemia
- T2DM (Type 2 Diabetes Mellitus)
- Bread
- Mango
-
New Delhi, Delhi, IndiaFortis CDOC Hospital
Sep 20, 2023